US Stock MarketDetailed Quotes

FOLD Amicus Therapeutics

Watchlist
  • 9.020
  • -0.440-4.65%
Close Jan 10 16:00 ET
  • 9.020
  • 0.0000.00%
Post 16:20 ET
2.70BMarket Cap-26.53P/E (TTM)

Amicus Therapeutics Key Stats

Amicus Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 140.801M--
--2024/Q4-- / 147.526M--
Nov 6, 20242024/Q3141.517M / 134.962M--
Aug 8, 20242024/Q2126.669M / 121.244M--
May 9, 20242024/Q1110.403M / 111.186M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 140.801M--
--2024/Q4-- / 147.526M--
Nov 6, 20242024/Q3141.517M / 134.962M--
Aug 8, 20242024/Q2126.669M / 121.244M--
May 9, 20242024/Q1110.403M / 111.186M--

Unlock Free Earnings Estimates

Amicus Therapeutics Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 31, 2024

Strong Buy

  • Buy

    80.00%
  • Hold

    20.00%
  • Sell

    0.00%

Price Target

No Data